ReviewAntibodies (Basel, Switzerland)2026
Potential Mechanisms of Partial/Transient Response or Resistance to Daratumumab Therapy: A Focus on Anti-Daratumumab Antibodies and Urinary Daratumumab Loss.
Marco Allinovi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.